Biotech

All Articles

Basilea scores $268M BARDA financing for antifungals, anti-biotics

.Basilea Pharmaceutica's job developing new antifungals has gotten a significant improvement coming ...

Capricor offers Europe civil rights to late-stage DMD treatment for $35M

.Having already scooped up the U.S. civil liberties to Capricor Therapies' late-stage Duchenne muscl...

FDA junks adcomm for Applied's uncommon ailment medicine

.After dismissing the decision date for Applied Therapeutics' metabolic problem drug govorestat, the...

Novo inks $600M NanoVation offer to analyze genetic drugs ex-liver

.Novo Nordisk is continuing its own press in to genetic medications, agreeing to compensate NanoVati...

Innovent links cytokine to colon cancer cells reactions

.Innovent Biologics has produced the scenario that its own checkpoint inhibitor-cytokine combination...

Merck, Daiichi ADC strikes goal in period 3 bronchi cancer cells research study

.A period 3 test of Daiichi Sankyo as well as Merck &amp Co.'s HER3-directed antibody-drug conjugate...

Rakovina deepens AI concentrate with collab to select cancer intendeds

.Five months after Rakovina Therapies turned toward artificial intelligence, the cancer-focused biot...

Ascendis' dwarfism medicine favorites in period 3, intimidates BioMarin

.Ascendis Pharma has actually emerged as a potential danger to BioMarin's Voxzogo, reporting phase 3...

Despite ph. 3 miss out on, Alkeus views road in advance for eye health condition possession

.Though Alkeus Pharmaceuticals' oral eye illness asset failed to significantly minimize geographical...

Kairos goes social along with $6M IPO to cash tests of cancer drug

.Along with a trio of biotechs hitting the Nasdaq on Friday, it was actually simple to overlook a sm...